Concepedia

Mark Hutchens

MH

Statistics

Publications

4

Citations

80

H-Index

4

Active since

2023

Affiliations

Moderna Therapeutics (United States)(Current)

Novavax (United States)

University of Pittsburgh

National Institute of Allergy and Infectious Diseases

Baylor College of Medicine

Mark Hutchens is an author at Moderna Therapeutics (United States) specializing in immunology, infectious diseases, and vaccinology.

Publications per year

2023–2023

4

Publications

4

Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults

Deborah Theodore, Angela R Branche, Lily Zhang et al. · JAMA Network Open · 2023 · 23 citations · Full text

, , +17

Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study

Guy de Bruyn, Joyce Wang, Annie Purvis et al. · EClinicalMedicine · 2023 · 23 citations · Full text

, , +17

Interim analysis of a phase 1 randomized clinical trial on the safety and immunogenicity of the mRNA-1283 SARS-CoV-2 vaccine in adults

Patrick Yassini, Mark Hutchens, Yamuna Devi Paila et al. · Human Vaccines & Immunotherapeutics · 2023 · 21 citations · Full text

, , +17

Risk of COVID-19 after natural infection or vaccination

Anne-Marie Rick, Matthew B. Laurens, Ying Huang et al. · EBioMedicine · 2023 · 13 citations · Full text

, , +17

1–4 of 4